Published in Ann Intern Med on May 01, 1978
Tumour lysis as a factor affecting blood levels of CEA. Br J Cancer (1982) 0.78
Evaluation of CEA in patients with known residual disease after resection of colonic cancer. J R Soc Med (1980) 0.75
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) (1985) 4.64
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Carcinoid tumors of the vermiform appendix. Cancer (1968) 3.07
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer (1991) 2.98
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet (1969) 2.94
Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med (1973) 2.81
Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr (1999) 2.79
Phytochelatin synthase genes from Arabidopsis and the yeast Schizosaccharomyces pombe. Plant Cell (1999) 2.74
Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med (1980) 2.72
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology (1976) 2.56
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Infrarenal abdominal aortic aneurysm: factors influencing survival after operation performed over a 25-year period. Ann Surg (1981) 2.51
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Incidence of high blood lead levels in Chicago children. Pediatrics (1969) 2.46
The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46
Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal (1998) 2.42
Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med (2001) 2.09
A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci (1989) 2.08
The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med (1977) 2.07
Brain metastases from colorectal carcinoma. The long term survivors. Cancer (1996) 2.01
Rad18 is required for DNA repair and checkpoint responses in fission yeast. Mol Biol Cell (1999) 1.98
Chemical basis of hashish activity. Science (1970) 1.94
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol (1991) 1.93
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol (1994) 1.93
Control of gastric emptying by osmolality of duodenal contents in man. Gastroenterology (1975) 1.92
Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology (1969) 1.92
Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology (1970) 1.86
Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med (1977) 1.85
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med (1977) 1.84
The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer (1976) 1.81
Radioimmunoassay of conjugated cholyl bile acids in serum. Gastroenterology (1973) 1.81
Mesenteric lipodystrophy. Ann Intern Med (1974) 1.80
Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79
Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum (1996) 1.77
Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci U S A (1999) 1.77
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res (1975) 1.75
Clinical management of advanced gastrointestinal cancer. Cancer (1975) 1.74
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci (1979) 1.72
Identification of transcription factor binding sites with variable-order Bayesian networks. Bioinformatics (2005) 1.70
Malignant lymphoma of bone. Cancer (1986) 1.66
Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology (1980) 1.65
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery (1985) 1.64
Rectal cancer following colectomy for polyposis. Arch Surg (1980) 1.63
25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med (1975) 1.61
The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci (2000) 1.61
Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med (1976) 1.59
Chemotherapy of gastrointestinal cancer. N Engl J Med (1978) 1.56
A prospective comparison of current diagnostic tests for pancreatic cancer. N Engl J Med (1977) 1.55
Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion. Duodenal perfusion studies in healthy subjects. Mayo Clin Proc (1974) 1.53
Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer (1984) 1.52
Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry (1994) 1.51
Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive products. J Clin Invest (1970) 1.51
The routine proctoscopic examination: a second look. Mayo Clin Proc (1966) 1.51
Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology (1977) 1.51
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50
Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc (1989) 1.50
A comparative evaluation of marketed analgesic drugs. N Engl J Med (1972) 1.50
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50
Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47